Both of these have a lot of details – far too many for me to capture what they are “about” in this short blog entry.
But, I can summarize them both very quickly! Vote NO!
The idea for each of these is to somehow offer discount prescription drugs to some set of low-income individuals. Each has a different set of benefits, each targets a different set of people. That idea is valiant, but each then ties into a bunch of complexities – including how these discounts are established, who benefits from the state & industry negotiation, who benefits from the new administration and overhead that needs to be created to establish these agencies. Lastly, the pro-78 folks are claiming that 79 allows for new mechanisms under which lawyers can file class-action lawsuits. Who knows.
Overall, it’s too complicated, too subtle, and has too many unknowns. On the other hand, it costs between $10M and $20M, and I’d rather we spend that money on somethat that we know is solid.